131 related articles for article (PubMed ID: 34636033)
1. COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Breccia M; Abruzzese E; Accurso V; Attolico I; Barulli S; Bergamaschi M; Binotto G; Bocchia M; Bonifacio M; Caocci G; Capodanno I; Castagnetti F; Cavazzini F; Crisà E; Crugnola M; Stella De Candia M; Elena C; Fava C; Galimberti S; Gozzini A; Gugliotta G; Intermesoli T; Iurlo A; La Barba G; Latagliata R; Leonetti Crescenzi S; Levato L; Loglisci G; Lucchesi A; Luciano L; Lunghi F; Luzi D; Malato A; Cristina Miggiano M; Pizzuti M; Pregno P; Rapezzi D; Rege-Cambrin G; Rosti G; Russo S; Sancetta R; Rita Scortechini A; Sorà F; Sportoletti P; Stagno F; Tafuri A; Tiribelli M; Foà R; Saglio G
Br J Haematol; 2022 Feb; 196(3):559-565. PubMed ID: 34636033
[TBL] [Abstract][Full Text] [Related]
2. The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
Bonifacio M; Tiribelli M; Miggiano MC; Abruzzese E; Binotto G; Scaffidi L; Cordioli M; Damiani D; Di Bona E; Trawinska MM; Tanasi I; Dubbini MV; Velotta V; Ceccarelli G; Pierdomenico E; Lo Schirico M; Semenzato G; Ruggeri M; Fanin R; Tacconelli E; Pizzolo G; Krampera M
Cancer Med; 2021 Sep; 10(18):6310-6316. PubMed ID: 34464516
[TBL] [Abstract][Full Text] [Related]
3. Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
Civettini I; Antolini L; Brioschi F; Zambrotta GPM; Guglielmana V; Gambacorti-Passerini C
Cancer Med; 2023 Apr; 12(8):9662-9667. PubMed ID: 37039261
[TBL] [Abstract][Full Text] [Related]
4. What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
Delgado N; Torres A
Curr Oncol Rep; 2022 May; 24(5):645-650. PubMed ID: 35218499
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia.
Cheng F; Xiang H; Gale RP; Chen S; Qu J; Guo H; Li Q; Zhang Y; Li W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11025-11030. PubMed ID: 37337067
[TBL] [Abstract][Full Text] [Related]
6. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Guarneri V; Bassan F; Zagonel V; Milella M; Zaninelli M; Cattelan AM; Vianello A; Gori S; Aprile G; Azzarello G; Chiari R; Favaretto A; Oliani C; Scola A; Pastorelli D; Mandarà M; Zustovich F; Bernardi D; Chiarion-Sileni V; Morandi P; Toso S; Di Liso E; Ziampiri S; Caccese M; Zampiva I; Puccetti O; Celestino M; Dieci MV; Conte P;
Eur J Cancer; 2021 Apr; 147():120-127. PubMed ID: 33647547
[TBL] [Abstract][Full Text] [Related]
8. Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.
Graf I; Herndlhofer S; Kundi M; Greiner G; Sperr M; Hadzijusufovic E; Valent P; Sperr WR
Eur J Haematol; 2023 Jan; 110(1):67-76. PubMed ID: 36193973
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in persons with chronic myeloid leukaemia.
Li W; Wang D; Guo J; Yuan G; Yang Z; Gale RP; You Y; Chen Z; Chen S; Wan C; Zhu X; Chang W; Sheng L; Cheng H; Zhang Y; Li Q; Qin J; ; Meng L; Jiang Q
Leukemia; 2020 Jul; 34(7):1799-1804. PubMed ID: 32424293
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 and chronic myeloid leukemia: a systematic review.
Ali EA; Al-Sadi A; Al-Maharmeh Q; Subahi EA; Bellamkonda A; Kalavar M; Panigrahi K; Alshurafa A; Yassin MA
Front Med (Lausanne); 2023; 10():1280271. PubMed ID: 38327268
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.
Giona F; Putti MC; Micalizzi C; Menna G; Moleti ML; Santoro N; Iaria G; Ladogana S; Burnelli R; Consarino C; Varotto S; Tucci F; Messina C; Nanni M; Diverio D; Biondi A; Pession A; Locatelli F; Piciocchi A; Gottardi E; Saglio G; Foà R
Br J Haematol; 2015 Aug; 170(3):398-407. PubMed ID: 25891192
[TBL] [Abstract][Full Text] [Related]
13. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
El-Ashwah S; Salmanton-García J; Bilgin YM; Itri F; Žák P; Weinbergerová B; Verga L; Omrani AS; Silva MGD; Szotkowski T; Marchetti M; Buquicchio C; Nucci M; Schönlein M; Farina F; Besson C; Prezioso L; Nizamuddin S; Dávila-Valls J; Martín-Pérez S; Bonuomo V; Van Doesum J; Tisi MC; Passamonti F; Méndez GA; Meers S; Maertens J; López-García A; Glenthøj A; Bonnani M; Rinaldi I; Ormazabal-Vélez I; Labrador J; Kulasekararaj A; Espigado I; Demirkan F; De Jonge N; Collins GP; Calbacho M; Blennow O; Al-Khabori M; Adžić-Vukičević T; Arellano E; Mišković B; Mladenović M; Nordlander A; Ráčil Z; Ammatuna E; Cordoba R; Hersby DS; Gräfe S; Emarah Z; Hanakova M; Sacchi MV; Ijaz M; Rahimli L; Nunes Rodrigues R; Zambrotta GPM; Marchesi F; Cornely OA; Pagano L
Leuk Lymphoma; 2024 Feb; 65(2):199-208. PubMed ID: 37966980
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.
Ector GICG; Huijskens EGW; Blijlevens NMA; Westerweel PE
Leukemia; 2020 Sep; 34(9):2533-2535. PubMed ID: 32641732
[No Abstract] [Full Text] [Related]
15. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
16. Early mortality in hip fracture patients admitted during first wave of the COVID-19 pandemic in Northern Italy: a multicentre study.
Dallari D; Zagra L; Cimatti P; Guindani N; D'Apolito R; Bove F; Casiraghi A; Catani F; D'Angelo F; Franceschini M; Massè A; Momoli A; Mosconi M; Ravasi F; Rivera F; Zatti G; Castelli CC
J Orthop Traumatol; 2021 Apr; 22(1):15. PubMed ID: 33818650
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
18. Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.
Flygt H; Sandin F; Dahlén T; Dremaine A; Lübking A; Markevärn B; Myhr-Eriksson K; Olsson K; Olsson-Strömberg U; Själander A; Söderlund S; Wennström L; Wadenvik H; Stenke L; Höglund M; Richter J
Br J Haematol; 2021 Jun; 193(5):915-921. PubMed ID: 33782950
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.
Ali EA; Khamees I; Abu-Tineh M; Qasim H; Alshurafa A; Ahmed K; Malkawi L; Yassin MA
Cureus; 2022 Apr; 14(4):e23863. PubMed ID: 35411288
[TBL] [Abstract][Full Text] [Related]
20. Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients.
McMullan RR; McConville C; McMullin MF
Ulster Med J; 2019 May; 88(2):105-110. PubMed ID: 31061559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
